(CIM) Chimera Investment - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US16934Q2084
CIM EPS (Earnings per Share)
CIM Revenue
CIM: Residential Loans, Mortgage-Backed Securities, Commercial Mortgage Loans
Chimera Investment Corporation is a mortgage real estate investment trust (REIT) that specializes in investing in a diverse portfolio of mortgage assets, including residential and commercial mortgage-backed securities, and other real estate-related securities. The companys investment strategy focuses on generating attractive risk-adjusted returns through a combination of interest income and potential capital appreciation.
As a REIT, Chimera is required to distribute at least 90% of its taxable income to shareholders in the form of dividends, making it an attractive investment opportunity for income-seeking investors. The companys investment portfolio is managed actively to optimize returns and minimize risk, with a focus on securities that offer a balance of yield and credit quality.
Chimeras investment portfolio includes a range of mortgage assets, such as residential mortgage loans, agency and non-agency residential mortgage-backed securities, and commercial mortgage-backed securities. The companys ability to invest in a broad range of securities allows it to diversify its portfolio and capitalize on opportunities in different segments of the mortgage market.
Based on the current technical and fundamental data, we can forecast that Chimera Investment Corporation is likely to continue its trend of stable dividend payments, given its REIT status and history of distributing a significant portion of its taxable income to shareholders. The companys current price of $13.88 is above its 50-day SMA of $13.52 and 200-day SMA of $13.66, indicating a positive trend. Additionally, the stocks P/E ratio of 8.82 and forward P/E ratio of 6.33 suggest that it may be undervalued relative to its earnings potential. With a market capitalization of $1.08 billion and a return on equity of 8.11%, Chimera Investment Corporation is well-positioned to continue delivering attractive returns to shareholders.
Using the available technical data, a potential trading strategy could be to buy CIM on a pullback to its 20-day SMA of $13.52, with a target price of $15.39, the 52-week high. The average true range (ATR) of 0.34, or 2.42%, suggests that the stock has a moderate level of volatility, making it a relatively stable investment opportunity. By combining technical and fundamental analysis, investors can make a more informed decision about investing in Chimera Investment Corporation.
Additional Sources for CIM Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
CIM Stock Overview
Market Cap in USD | 1,108m |
Sector | Real Estate |
Industry | REIT - Mortgage |
GiC Sub-Industry | Mortgage REITs |
IPO / Inception | 2007-11-16 |
CIM Stock Ratings
Growth Rating | -37.1 |
Fundamental | 34.3 |
Dividend Rating | 31.0 |
Rel. Strength | -0.25 |
Analysts | 3.6 of 5 |
Fair Price Momentum | 13.86 USD |
Fair Price DCF | 52.25 USD |
CIM Dividends
Dividend Yield 12m | 10.62% |
Yield on Cost 5y | 8.55% |
Annual Growth 5y | -19.50% |
Payout Consistency | 78.8% |
Payout Ratio | 98.0% |
CIM Growth Ratios
Growth Correlation 3m | 69.9% |
Growth Correlation 12m | -32.9% |
Growth Correlation 5y | -71.5% |
CAGR 5y | -4.26% |
CAGR/Max DD 5y | -0.06 |
Sharpe Ratio 12m | 0.12 |
Alpha | 4.73 |
Beta | 0.612 |
Volatility | 33.25% |
Current Volume | 899.4k |
Average Volume 20d | 553.4k |
As of June 22, 2025, the stock is trading at USD 13.73 with a total of 899,428 shares traded.
Over the past week, the price has changed by -1.93%, over one month by -0.87%, over three months by +3.66% and over the past year by +12.50%.
Neither. Based on ValueRay´s Fundamental Analyses, Chimera Investment is currently (June 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 34.26 and therefor a neutral outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CIM is around 13.86 USD . This means that CIM is currently overvalued and has a potential downside of 0.95%.
Chimera Investment has received a consensus analysts rating of 3.60. Therefor, it is recommend to hold CIM.
- Strong Buy: 1
- Buy: 1
- Hold: 3
- Sell: 0
- Strong Sell: 0
According to our own proprietary Forecast Model, CIM Chimera Investment will be worth about 15 in June 2026. The stock is currently trading at 13.73. This means that the stock has a potential upside of +9.03%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 15.8 | 14.7% |
Analysts Target Price | 15.8 | 14.7% |
ValueRay Target Price | 15 | 9% |